Ingalls & Snyder LLC’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $141K | Hold |
51,849
| – | – | 0.01% | 427 |
|
|
2025
Q1 | $176K | Hold |
51,849
| – | – | 0.01% | 403 |
|
|
2024
Q4 | $214K | Hold |
51,849
| – | – | 0.01% | 389 |
|
|
2024
Q3 | $129K | Hold |
51,849
| – | – | 0.01% | 415 |
|
|
2024
Q2 | $137K | Hold |
51,849
| – | – | 0.01% | 388 |
|
|
2024
Q1 | $107K | Hold |
51,849
| – | – | ﹤0.01% | 408 |
|
|
2023
Q4 | $93K | Hold |
51,849
| – | – | ﹤0.01% | 407 |
|
|
2023
Q3 | $71K | Buy |
51,849
+1,000
| +2% | +$1.37K | ﹤0.01% | 399 |
|
|
2023
Q2 | $70K | Hold |
50,849
| – | – | ﹤0.01% | 402 |
|
|
2023
Q1 | $120K | Hold |
50,849
| – | – | 0.01% | 387 |
|
|
2022
Q4 | $116K | Sell |
50,849
-300
| -0.6% | -$684 | 0.01% | 395 |
|
|
2022
Q3 | $141K | Hold |
51,149
| – | – | 0.01% | 382 |
|
|
2022
Q2 | $125K | Hold |
51,149
| – | – | 0.01% | 395 |
|
|
2022
Q1 | $202K | Hold |
51,149
| – | – | 0.01% | 414 |
|
|
2021
Q4 | $226K | Hold |
51,149
| – | – | 0.01% | 402 |
|
|
2021
Q3 | $316K | Hold |
51,149
| – | – | 0.01% | 353 |
|
|
2021
Q2 | $405K | Hold |
51,149
| – | – | 0.02% | 326 |
|
|
2021
Q1 | $547K | Buy |
+51,149
| New | +$547K | 0.03% | 272 |
|